Parkinson's disease (PD) is the most common neurodegenerative movement disorder mainly due to gradual loss of dopaminergic neurons in the substantia nigra. Although the causative genes for autosomal recessive PD, Parkin, PINK1 and DJ-1, share a common pathway, at least in part, in mitochondrial quality control and protein quality control, their precise relationship remains elusive. Previous studies suggested the limitation of gene-modified mice model to solve this problem. DT40 is an avian leukosis virus-induced chicken B cell line with an exceptionally high ratio of targeted to random DNA integration, which enables efficient targeted disruption of multiple genes of interest. We generated DJ-1-deficient DT40 cells and analyzed PD-related phenotypes. These cells exhibited vulnerability to oxidative stress, mitochondrial dysfunction and fragmentation. Importantly, we showed that mitochondrial membrane potential and morphology are available for the phenotype analysis in DT40. These results suggest that genetically engineered DT40 cells would serve as a relevant model of PD, and help understand the genetic and functional relationship among multiple causative genes. Furthermore, in line with the recent concept of PD as a systemic disorder, elucidating the pathomechanism of PD using DT40 would lead to the development of noninvasive diagnostic tools and drug screening assays using patient-derived lymphocytes.
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Introduction
Parkinson's disease (PD) is the most common neurodegenerative movement disorder that causes progressive motor symptoms mainly due to gradual loss of dopaminergic neurons in the substantia nigra pars compacta (de Lau and Breteler, 2006) . Treatments that provide neuroprotection and/or disease-modifying
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* Corresponding author. effects remain an unmet clinical need because currently available dopamine replacement therapies only partially improve the symptoms (Meissner et al., 2011) .
Though PD is typically sporadic in origin, identification of genes responsible for familial PD has provided clues to understand the pathogenesis of the more common, sporadic form of PD (Moore and Dawson, 2008) . Parkin, PINK1 and DJ-1 are causative genes of autosomal recessive PD, in which clinical phenotype is often indistinguishable from early-onset idiopathic PD (Kitada et al., 1998; Valente et al., 2004; Bonifati et al., 2003) . Identification of these genes has promoted generation of gene-modified models to investigate the pathomechanisms of the disease (Shulman et al., 2011) .
Recent studies have revealed that these genes share, at least in part, a common pathway in mitochondria quality control and protein quality control. Genetic studies using Parkin and PINK1 knockout Drosophila indicated that PINK1 acts upstream of Parkin (Clark et al., 2006; Park et al., 2006; Yang et al., 2006) . Further studies elucidated that Parkin and PINK1 share a common mitochondrial quality control pathway conserved in mammalian cells (Narendra and Youle, 2011; Matsui et al., 2013) . Meanwhile, it is still controversial whether DJ-1 works in association with PINK1/Parkin
